GGrantIndex
Sort

78,016 grants matching breast cancer

PERIODIC FASTING-MIMICKING DIET AS A STRATEGY TO INCREASE THE EFFECTIVENESS OF HORMONE THERAPIES IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

$978,057
University Of Southern California · · FY2017 · Department of the Army

Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures

$977,907
Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2017 · ES

Objective Physical Activity and Cardiovascular Health in Women Aged 80 and Older

$977,906
Andrea Z. Lacroix · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL

Breast Cancer Survival: Lifestyle and Genetic Determinants

$977,864
Xiao-Ou Shu · Vanderbilt University · R01 · FY2009 · CA

Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial

$977,596
Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer Detection

$977,588
David T Wong · University Of California Los Angeles · UH3 · FY2016 · TR

Redes En Accion::The National Hispanic/Latino Cancer Network Research Network

$977,248
Amelie G Ramirez · University Of Texas Hlth Science Center · U54 · FY2014 · CA

PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP

$977,147
Ctr For Molecular Medicine/Immunology · R01 · FY2004 · CA

Integrated analyses of genetics, epigenetics, and gene expression

$977,108
Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2016 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$977,015
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2019 · CA

High-speed panoramic 3D photoacoustic computed tomography of the breast

$976,958
Lihong Wang · California Institute Of Technology · R35 · FY2023 · CA

High-speed panoramic 3D photoacoustic computed tomography of the breast

$976,957
Lihong Wang · California Institute Of Technology · R35 · FY2022 · CA

Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences

$976,789
Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2016 · CA

Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention

$976,725
Jennifer S Haas · Massachusetts General Hospital · U01 · FY2018 · CA

Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities

$976,573
Craig M Crews · Yale University · R35 · FY2025 · CA

Bay Area Cancer Target Discovery and Development

$976,551
Michael T McManus · University Of California, San Francisco · U01 · FY2023 · CA

South Carolina Cancer Disparities Research Center (SC CADRE)

$976,404
Marvella Elizabeth Ford · Medical University Of South Carolina · U54 · FY2019 · CA

Integrating targeted therapy and immunotherapy to break through cancer

$976,251
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2024 · CA

GENETIC AND FUNCTIONAL ANALYSIS OF THE ROLE OF CLONAL TUMOR-INFILTRATING LEUKOCYTES IN BREAST CANCER PATHOGENESIS AND THERAPY

$976,157
Sloan-Kettering Institute For Cancer Research · · FY2015 · Department of the Army

Howard/Hopkins Cancer Centers Partnership

$976,090
William George Nelson · Johns Hopkins University · U54 · FY2009 · CA

Understanding and Addressing Cancer Health Disparities in Louisiana

$976,081
Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2018 · CA

Studies of Occupational Cancer (Pesticides)

$975,974
Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy

$975,880
Ac Matin · Stanford University · UH3 · FY2016 · TR

HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy

$975,880
Ac Matin · Stanford University · UH3 · FY2017 · TR

Carle Cancer Center Community Clinical Oncology Program

$975,842
Carle Foundation · U10 · FY2005 · CA